Genzyme rejects Sanofi offer as long battle looms
by on Aug.31, 2010, under Health and Fitness
Biotech company Genzyme Inc rejected an $18.5 billion buyout offer from French drugmaker Sanofi-Aventis SA on Monday, setting the stage for a protracted and potentially hostile takeover battle.
View full post on Yahoo! Health News
